AT1 0.00% 2.7¢ atomo diagnostics limited

Media Update, page-1083

  1. 572 Posts.
    lightbulb Created with Sketch. 55
    Thanks @Hdavid92, I get that and yes that's great but if we're locked into a few cents per test then it's not going to be meaningful. I just don't understand why it would be some huge secret.

    Very simplistically - just trying to backsolve/sense check based on average industry data which I've found:
    • Assuming AT1's tests sell for $15 (before any g'ment subsidies)
    • Pharmacy margins are around 22-25% (on higher-end for non-prescription products) - so I'll take 25% to be cautious
    • = $12 wholesale price
    • Device distribution margins are generally around 40%, but given the high volume and white-labelling, let's low-ball it and assume half that @ 20%. You'd probably assume higher given Access Bio over a barrel due to the antibody test hiccup
    • = $2.40
    Distributor margins to include all freight and packaging costs. No promotional materials required given it's a B2B sale.

    How wrong am I on this?
 
watchlist Created with Sketch. Add AT1 (ASX) to my watchlist
(20min delay)
Last
2.7¢
Change
0.000(0.00%)
Mkt cap ! $17.25M
Open High Low Value Volume
2.8¢ 2.9¢ 2.7¢ $10.03K 365.9K

Buyers (Bids)

No. Vol. Price($)
7 668702 2.7¢
 

Sellers (Offers)

Price($) Vol. No.
2.8¢ 11840 2
View Market Depth
Last trade - 16.10pm 24/06/2024 (20 minute delay) ?
AT1 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.